Breaking
Thursday, October 15
S&P 500 $769.60 ▼ 1.08%Nasdaq 100 $728.95 ▼ 1.97%10Y Yield 5.21%
Embers

Push Notifications

Notifications only deliver through the Embers Android app. This preference is saved and will take effect once you open the site there.

Mastodon
Markets

Innovative Industrial Prices $50M Preferred Stock Issue

Innovative Industrial Properties priced a $50 million offering of 9.25% Series B preferred stock at $25 per share to fund life science commitments.

By Muhamed Porić

October 15, 2026 at 11:55 AM

Photo by Rafael Minguet Delgado on Pexels

Innovative Industrial Properties has priced a public offering of 2 million shares of its 9.25% Series B Cumulative Redeemable Preferred Stock at $25.00 per share, targeting $50 million in gross proceeds to fund life science industry commitments. The real estate investment trust structured the offering to close on October 19, 2026, while granting underwriters a 30-day option to buy up to 300,000 additional shares to cover overallotments.

How Cumulative Redeemable Preferred Stock Operates

Preferred stock sits between debt and common equity in a company's capital structure, prioritizing dividend payments over common shareholders. Cumulative preferred stock requires the issuer to pay any missed dividend distributions before resuming dividends on common shares, offering income-focused investors added downside protection compared to standard equity.

The newly priced Series B shares are slated to trade on the New York Stock Exchange under the ticker symbol IIPR Pr B, according to reporting from Investing.com. Stifel is acting as the active bookrunner for the transaction, supported by a syndicate of passive bookrunners and co-managers handling the underwriting book.

Use of Proceeds and Life Science Commitments

Net proceeds from the $50 million offering are earmarked primarily to satisfy remaining unfunded capital commitments under a previously disclosed mezzanine loan investment tied to the life science sector. Any remaining capital will be directed toward general corporate purposes and prospective property investments.

The deployment into life science commitments marks a capital allocation strategy for the real estate firm, which traditionally focuses on specialized industrial properties. By utilizing a fixed-income-style preferred equity instrument, the company secures capital without diluting existing common shareholders while addressing its sector-specific funding obligations.

Innovative Industrial PropertiesIIPRPreferred StockReal Estate Investment TrustLife Sciences
Sponsored

Torches.io

Post your startup or app, get verified, and get discovered by real investors. Or browse vetted projects and invest directly.

Explore Torches.io

Muhamed Porić

Founder and Editor of Embers.

Newsletter

Get Embers in your inbox

The stories that actually moved something, delivered when there's something worth sending, not daily filler.

Related Stories